HORIZON KINETICS ASSET MANAGEMENT LLC
Position in RPRX — Royalty Pharma plc
CIK 1056823
NEW YORK, NY
Position in RPRX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$19,336,356
+$2,988,996 QoQ
Shares Held
344,861
+1.2% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#109
of 644 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HORIZON KINETICS ASSET MANAGEMENT LLC holds $23,045,365 across 14 Biotechnology names. RPRX ranks #1 (83.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
This page
|
344,861 | $19,336,356 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
10,904 | $864,578 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,168 | $652,633 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
9,353 | $510,112 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
645 | $402,183 | |
| 6 | BEAM |
Beam Therapeutics Inc.
|
8,388 | $287,876 | |
| 7 | GALT |
Galectin Therapeutics Inc
|
46,968 | $217,931 | |
| 8 | NTLA |
Intellia Therapeutics, Inc.
|
12,584 | $212,921 |
All Filings in RPRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,336,356 | 344,861 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $16,347,360 | 340,783 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,653,869 | 353,361 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $12,513,286 | 354,685 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $12,735,560 | 353,471 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $10,259,514 | 329,570 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $8,142,179 | 319,176 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $6,472,638 | 228,796 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,033,034 | 228,784 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,082,746 | 200,288 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $6,086,822 | 216,690 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $7,796,100 | 287,255 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $10,256,985 | 333,669 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $13,443,513 | 373,120 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $15,803,257 | 399,880 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $16,415,378 | 408,546 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $19,067,494 | 453,556 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $15,230,165 | 390,918 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $11,259,099 | 282,537 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $8,685,453 | 240,328 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,741,404 | 213,257 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,170,749 | 49,765 | Shares | Defined | 2021-05-11 | |
| No filing history on record for this holder in this stock. | ||||||